FindTrial
Sign In

Urinalysis

DIAGNOSTIC_TEST15 trials

Sponsors

St.Marianna University School of Medicine, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Imperial College London, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Clinical Research Support Center Kyush

Conditions

AnthraxAsthmaBladder CancerChronic Kidney DiseasesDiabetes MellitusDown SyndromeHealthy Men Age 18-50 With no Urethral SymptomsHealthy Volunteers

Phase 1

Anthrax Vaccine Clinical Trials
CompletedNCT00114621
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Anthrax
Start: 2004-09-08End: 2011-05-25Updated: 2017-07-02
Oral Nifedipine to Treat Iron Overload
CompletedNCT00712738
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Hemochromatosis, Iron Overload, Thalassemia
Start: 2008-06-20End: 2010-09-22Updated: 2017-07-02
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases
CompletedNCT05435638
Kamari Pharma LtdPachyonychia Congenita, Punctate Palmoplantar Keratoderma Type 1
Start: 2022-07-17End: 2024-09-05Updated: 2025-01-07
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
CompletedNCT05454462
Kamari Pharma LtdLichen Simplex Chronicus
Start: 2022-05-24End: 2023-04-04Updated: 2024-04-02
Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
CompletedNCT05956314
Kamari Pharma LtdPachyonychia Congenita, Punctate Palmoplantar Keratoderma Type 1
Start: 2023-03-06End: 2024-11-07Updated: 2025-01-15
UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
RecruitingNCT06737380
LiveKidney.BioLupus, SLE, Systemic Lupus Erthematosus +2
Start: 2025-01-07End: 2026-07-31Target: 10Updated: 2025-09-11
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
RecruitingNCT07079930
Hadassah Medical OrganizationHealthy Volunteers
Start: 2025-12-11End: 2027-02-01Target: 10Updated: 2026-02-05

Phase 2

TNF-alpha Directed Therapy in Asthma
CompletedNCT00278083
Imperial College LondonAsthma
Start: 2001-10-31End: 2004-04-30Target: 40Updated: 2023-09-14
Oral Steroids for Regorafenib-induced Fatigue/Malaise in Unresectable mCRC (KSCC1402/HGCSG1402)
NCT02288078
Clinical Research Support Center KyushRectal Cancer
Start: 2014-10-31End: 2016-09-30Target: 74Updated: 2014-11-13

Unknown Phase

Correlation Between Optic Nerve Vessel Anomalies, Serum Angiogenic Factors and Renal Anomalies in Down Syndrome Children
NCT03206957
Queen Fabiola Children's University HospitalDown Syndrome
Start: 2017-11-30End: 2019-06-01Target: 200Updated: 2018-07-05
Chronic Kidney Disease and Cardiovascular Disease Risk Assessment
WithdrawnNCT03975439
Pacific Northwest University of Health SciencesChronic Kidney Diseases, Diabetes Mellitus, Hypertension
Start: 2020-02-01End: 2020-02-05Updated: 2022-07-14
Brain Imaging in Men With Lower Urinary Tract Symptoms
CompletedNCT03991429
The Methodist Hospital Research InstituteVoiding Disorders
Start: 2019-06-04End: 2022-07-31Updated: 2023-01-05
Relationship between salt intake and lifestyle, blood pressure among the working population
Active, not recruitingJPRN-UMIN000043658
St.Marianna University School of MedicineWorkers who have undergone a regular medical examination
Start: 2023-04-01Target: 6500Updated: 2025-07-18
Bladder Cancer Screening Trial
RecruitingNCT05646485
University of Texas Southwestern Medical CenterBladder Cancer, Hematuria, Smoking Cessation +1
Start: 2023-05-05End: 2028-04-30Target: 1000Updated: 2025-04-13
Establishing Baseline Sysmex UF-5000 Flow Cytometer Results in Healthy Men
CompletedNCT06951009
Indiana UniversityHealthy Men Age 18-50 With no Urethral Symptoms, Urethritis
Start: 2025-04-09End: 2025-05-07Updated: 2025-07-18

Related Papers

Patient reported outcomes (PRO) results for prophylactic effect of dexamethasone on regorafenib-related fatigue and/or malaise: a randomized, placebo-controlled, double-blind clinical study in patients with unresectable metastatic colorectal cancer: KSCC1402/HGCSG1402.
Journal of Clinical Oncology2018-05-20